摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-chloro-4-methoxyphenyl)-2-aminoethanol | 778536-58-6

中文名称
——
中文别名
——
英文名称
1-(3-chloro-4-methoxyphenyl)-2-aminoethanol
英文别名
2-Amino-1-(3-chloro-4-methoxyphenyl)ethan-1-ol;2-amino-1-(3-chloro-4-methoxyphenyl)ethanol
1-(3-chloro-4-methoxyphenyl)-2-aminoethanol化学式
CAS
778536-58-6
化学式
C9H12ClNO2
mdl
——
分子量
201.653
InChiKey
FNZGVRAIYSDTRZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    359.0±42.0 °C(Predicted)
  • 密度:
    1.259±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    55.5
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-4-iodo-1H-pyridin-2-one 、 1-(3-chloro-4-methoxyphenyl)-2-aminoethanolN,N-二甲基甲酰胺 为溶剂, 生成 (+/-)-4-[2-(3-chloro-4-methoxy-phenyl)-2-hydroxy-ethylamino]-3-(6-imidazol-1-yl-4-methyl-1H-benzimidazol-2-yl)-1H-pyridin-2-one
    参考文献:
    名称:
    Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase
    摘要:
    A novel class of 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase is described. This report discusses the SAR of 4-(2-hydroxy-2-phenylethylamino)-substituted pyridones with improved IGF-1R potency. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2006.11.041
  • 作为产物:
    描述:
    3-氯-4-羟基苯甲酸manganese(IV) oxidesodium hydroxide硫酸硼烷potassium carbonate 、 zinc(II) iodide 作用下, 以 四氢呋喃二氯甲烷丙酮 为溶剂, 反应 50.0h, 生成 1-(3-chloro-4-methoxyphenyl)-2-aminoethanol
    参考文献:
    名称:
    Evaluation of isomeric 4-(chlorohydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines as dopamine D-1 antagonists
    摘要:
    The isomeric 4-(3-chloro-4-hydroxyphenyl)- and 4-(4-chloro-3-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines, the N-methyl derivative of the 4-(4-chloro-3-hydroxyphenyl) isomer, and 4-(3-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline were synthesized and evaluated for dopamine D-1 antagonist activity. The 4-(3-chloro-4-hydroxyphenyl) and the 4-(3-hydroxyphenyl) isomer possessed similar potencies as D-1 antagonists. Introduction of the N-methyl group enhanced potency about twofold. The "pharmacophore" for selective dopamine D-1 antagonist activity appears to be a tertiary 2-(3-hydroxyphenyl)-2-phenethylamine.
    DOI:
    10.1021/jm00393a033
点击查看最新优质反应信息

文献信息

  • Evaluation of isomeric 4-(chlorohydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines as dopamine D-1 antagonists
    作者:Robert M. Riggs、David E. Nichols、Mark M. Foreman、Lewis L. Truex
    DOI:10.1021/jm00393a033
    日期:1987.10
    The isomeric 4-(3-chloro-4-hydroxyphenyl)- and 4-(4-chloro-3-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines, the N-methyl derivative of the 4-(4-chloro-3-hydroxyphenyl) isomer, and 4-(3-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline were synthesized and evaluated for dopamine D-1 antagonist activity. The 4-(3-chloro-4-hydroxyphenyl) and the 4-(3-hydroxyphenyl) isomer possessed similar potencies as D-1 antagonists. Introduction of the N-methyl group enhanced potency about twofold. The "pharmacophore" for selective dopamine D-1 antagonist activity appears to be a tertiary 2-(3-hydroxyphenyl)-2-phenethylamine.
  • Novel 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase
    作者:Mark D. Wittman、Balu Balasubramanian、Karen Stoffan、Upender Velaparthi、Pieying Liu、Subramaniam Krishnanathan、Joan Carboni、Aixin Li、Ann Greer、Ricardo Attar、Marco Gottardis、Chiehying Chang、Bruce Jacobson、Yax Sun、Steven Hansel、Mary Zoeckler、Dolatrai M. Vyas
    DOI:10.1016/j.bmcl.2006.11.041
    日期:2007.2
    A novel class of 1H-(benzimidazol-2-yl)-1H-pyridin-2-one inhibitors of insulin-like growth factor I (IGF-1R) kinase is described. This report discusses the SAR of 4-(2-hydroxy-2-phenylethylamino)-substituted pyridones with improved IGF-1R potency. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多